Evaluation of efficacy of pooled sera in a human immunodeficiency virus antibody prevalence in population surveys.

Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Evaluation of efficacy of pooled sera in a human immunodeficiency virus antibody prevalence in population surveys.

Rev Roum Virol. 1990 Jan-Mar;41(1):45-51. Unique Identifier : AIDSLINE MED/91027604
Patrascu IV; Stefan S. Nicolau, Institute of Virology, Bucharest, Romania.

Abstract: The pooling of five individual serum samples for the detection of human immunodeficiency virus type 1 (HIV-1) antibodies was examined to assess whether testing pooled versus individual sera was technically feasible. Detection of HIV-1 antibodies was performed using a competitive enzyme immunoassay (EIA) Wellcozyme HIV Recombinant commercially available kit. Positive, weak positive and negative sera or HIV-1 antibody from Wellcozyme HIV Recombinant, Du Pont ELISA, SERODIA HIV Mast Diagnostica and from Stefan S. Nicolau Institute of Virology (NIV) collection were pooled in various dilutions with control negative sera for HIV-1 antibodies. When positive sera were pooled 1:4 with negative sera, results remained reactive in the same range of positivity and when cut off-control sera were pooled 1:4 with negative sera samples remained in the cut off range. For reliability we considered cut of values of pooled sera probes an A 450 absorbance 0.2 units higher than the absorbance of cut-off-control from Wellcozyme HIV Recombinant kit B. Samples of pooled sera that have absorbance A 450 lower, equal or 0.2 units higher than the absorbance of cut off-control of Wellcozyme were considered positive and the five sera were tested as individual probes. The positive probes thus found were retested in duplicate using the original sample source. Negative samples of pooled sera do not have to be retested, this being the main advantage of this technique. Also positive sera (controls of from NIV collection) were pooled with HIV-1 antibody negative sera which were positive for rheumatoid factor (RF).(ABSTRACT TRUNCATED AT 250 WORDS)

Keywords: Acquired Immunodeficiency Syndrome/IMMUNOLOGY Adult AIDS-Related Complex/IMMUNOLOGY Blood Donors Child Comparative Study Enzyme-Linked Immunosorbent Assay Evaluation Studies Human HIV Antibodies/*BLOOD HIV Seropositivity/*EPIDEMIOLOGY HIV-1/*IMMUNOLOGY Population Surveillance Prevalence Reagent Kits, Diagnostic Romania/EPIDEMIOLOGY JOURNAL ARTICLE
910228
M9120670

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .